Nanotechnology: Containment Strategies and Engineering Controls

Sep 26, 2017

Control measures for nanoparticles, dusts, and other hazards should be implemented within the context of a comprehensive occupational safety and health management system [ANSI/AIHA 2012]. The critical elements of an effective occupational safety and health management system include management commitment and employee involvement, worksite analysis, hazard prevention and control, and sufficient training for employees, supervisors, and managers.

In developing measures to control occupational exposure to nanomaterials, it is important to remember that processing and manufacturing involve a wide range of hazards. Conducting a preliminary hazard assessment (PHA) encompasses a qualitative life cycle analysis of an entire operation, appropriate to the stage of development:

PHAs are frequently conducted as initial risk assessments to determine whether more sophisticated analytical methods are needed and to prepare an inventory of hazards and control measures needed for these hazards. As part of the assessment, the health and safety professional should evaluate the magnitude of the emissions (or potential emissions) and the effects of exposure to these emissions. PHAs are an important first step toward developing control measures that can be considered during the planning stage. Essentially, hazard control should be an integral component of facility, process, and equipment design and construction. This includes design for inherent process safety. The use of engineering controls should be considered as part of a comprehensive control strategy for hazards associated with processes/ tasks that cannot be effectively eliminated, substituted for, or contained through process equipment modifications.

  1. Prevention through Design (PtD)

The concept of Prevention through Design (PtD) is to design out or minimize hazards, preferably, early in the design process. PtD is also called inherent or intrinsic safety, safety by design, design for safety, and safe design. When PtD is implemented, the control hierarchy is applied by designers (e.g., engineers, architects, industrial designers) and business leaders (e.g., owners, purchasers, managers) who consider the benefits of designing safety into things external to the worker to prevent work-related injuries and illnesses.

Other PtD strategies can be considered:

PtD strategies typically do not include administrative controls and personal protective equipment (PPE) as the primary controls. These measures require worker interaction with the process or active steps to limit the extent of the hazard. Most effective PtD approaches reduce or eliminate hazardous conditions without relying on input from workers. Humans are generally recognized as being much less reliable than most machines, particularly in emergencies [Kletz 2001]. The use of administrative controls and PPE in PtD strategies is generally for redundancy—further safeguards should the primary control fail.

  1. OELs as Applied to Nanotechnology

Occupational exposure limits (OELs) are useful in reducing work-related health risks by providing a quantitative guideline and basis to assess the worker exposure potential and the performance of engineering controls and other risk management approaches. Currently, no regulatory standards for nanomaterials have been established in the United States. However, NIOSH has recently published two current intelligence bulletins (CIBs) regarding occupational exposures to nanomaterials. In a CIB on titanium dioxide (TiO2 ), NIOSH recommends exposure limits of 2.4 mg/m3 for fine TiO2 and 0.3 mg/m3 for ultrafine (including engineered nanoscale) TiO2 , as time-weighted average (TWA) concentrations for up to 10 hours per day during a 40-hour work week [NIOSH 2011]. In a CIB on carbon nanotubes and nanofibers, NIOSH recommends that worker exposure be limited to no more than 1 µg/m3 [NIOSH 2013].

1.3.3 Control Banding

Control banding is a qualitative risk characterization and management strategy, intended to protect the safety and health of workers in the absence of chemical and workplace standards. Control banding groups workplace risks into hazard bands based on evaluations of hazard and exposure information [NIOSH 2009b]. Note that control banding is not intended to be a substitute for OELs and does not alleviate the need for environmental monitoring or industrial hygiene expertise.

To determine the appropriate control scheme, one should consider the characteristics of the substance, the potential for exposure, and the hazard associated with the substance. Four main control bands, based on an overall risk level, have been developed:

Engineering Controls



Current Strategies for Engineering Controls in Nanomaterial Production and Downstream Handling Processes, Department of Health and Human Services, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health

Other News

Antibody Drug Conjugates: The New Wave of Pharmaceuticals

Date: Feb 05, 2018

Blood Cell Labeling 101

Date: Feb 01, 2018

Esco Healthcare Welcomes 2018!

Date: Jan 08, 2018

Isolator-like hot cells are burning this 2018!

Date: Jan 04, 2018

Esco Pharma at the 52nd ASHP Midyear Clinical Meeting and Exhibition 2017

Date: Dec 15, 2017

Raising Your Standards with Esco Downflow Booth
Airflow Containment on Its Best

Date: Nov 29, 2017

Bio-decontamination Within
The Efficiency of Esco BioVap™ Inside the Isolators

Date: Nov 28, 2017

Esco Pharma GB exhibited at CPhI and P-Mec in Germany

Date: Nov 08, 2017

Survivor 101: Safe Change Filtration

Date: Nov 07, 2017

The Horror Behind the Gross Art of Sneeze and Cough

Date: Oct 27, 2017

Esco Life Sciences and Healthcare is Strengthening its Core in Biocontainment

Date: Oct 18, 2017

Esco Pharma is at Two Places at Once

Date: Oct 05, 2017

A Perfect Mate

Date: Sep 27, 2017

It’s more than just being Fragile : How to Handle Potent Formulation?

Date: Sep 25, 2017

Innovative Solutions for the Next Generation: Esco Pharma at ISPE 2017

Date: Aug 30, 2017

How SAFE is your FOOD?

Date: Aug 30, 2017

Nanotechnology in Pharmaceutical R&D: Drug Delivery System

Date: Jul 25, 2017

Inhaled Insulin: Boon or Bane?

Date: Aug 11, 2017

Esco Pharma at High Potent Medicines Conference 2017

Date: Jun 21, 2017

Quality Assurance System

Date: Jun 16, 2017


Date: Jun 16, 2017

Esco Pharma GB is moving!

Date: May 30, 2017

Esco Pharma at INTERPHEX 2017

Date: Apr 04, 2017

Esco Isoclean® Isolators Aid in a Pharmacy Compounding Facility in Singapore

Date: Mar 17, 2017

Esco Pharma Advancing Aseptic Pharmaceutical Processing with SP Scientific PennTech and ESS Technologies

Date: Jan 26, 2017

Esco joins the biggest pharma event in South Asia!

Date: Nov 28, 2016

Feeling Alienated by Safety?

Date: Dec 01, 2016

Blow-Fill-Seal Technology and Isolators

Date: Nov 22, 2016

How Clean is Clean Enough?

Date: Nov 08, 2016

Why isolators are still preferred when handling HPAPIs?

Date: Oct 27, 2016

Be SAFE in Handling High Potency APIs

Date: Oct 26, 2016

Cytotoxic Drugs: Safe Handling in the Workplace!

Date: Oct 17, 2016

Esco isolator finally arrives in the land of the rising sun

Date: Sep 26, 2016

Esco Healthcare exhibits at the 16th ISPE – Singapore Affiliate

Date: Sep 16, 2016

Unidirectional or Turbulent Airflow: Which is best for Sterile Pharmacy Compounding?

Date: Sep 01, 2016

Discover the most diverse compounding pharmacy isolators

Date: Aug 18, 2016

The need for engineering controls in preventing compounding pharmacy mishaps

Date: Jul 19, 2016

Esco at the ASHP in Baltimore!

Date: Jun 23, 2016

Esco at the 2016 PPhA National Convention in Cebu City

Date: Jun 01, 2016

Esco Pharma ships out General Processing Platform Isolator (GPPI) to a client in Canada

Date: Jan 04, 2016

Esco Launches VacciXcell and TapestleRx

Date: Dec 03, 2015

VacciXcell commences the 1st day of exhibition at the Europe Vaccine Congress 2015 in Madrid

Date: Nov 10, 2015

Esco Pharma exhibited concurrently in Pharma Expo Las Vegas and IPEX Packaging Expo in Jakarta

Date: Oct 07, 2015

Esco Pharma partners with UP College of Pharmacy

Date: Jul 09, 2015

Thank you for visiting Esco at ACHEMA 2015!

Date: Jun 26, 2015

Esco at ISPE Exhibition

Date: Jun 09, 2015

Esco Pharma is Proud to Launch its New Range of Containment Isolators

Date: Apr 28, 2015

Esco GB Ltd hosted the 2014 Training at its new premises in Barnsley

Date: Dec 15, 2014

Esco Pharma at ISPE Event in Singapore.

Date: Aug 13, 2014

Esco at INTERPHEX 2014!

Date: Jul 17, 2014